GSK to launch once every 3 month injectable drug for osteoporosis.

Published: 2007-07-30 06:58:00
Updated: 2007-07-30 06:58:00
GSK Korea announced to launch Bonviva (ibandronate), an anti-osteoporosis therapy for menopause women, once every 3 month injectable administration via intra-vein.

Bonviva is a class of the biphosphonate drugs with an excellent efficacy and tolerance approved locally as an oral drug, administe...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.